Jeff Dunn is the CEO and founder of Redivus Health, a prominent healthcare technology company focused on improving patient safety and outcomes through innovative solutions. Redivus Health, headquartered in Overland Park, Kansas, provides clinical decision support at the point of care to reduce medical errors during critical healthcare events such as cardiac arrest, stroke, and sepsis. Jeff Dunn is a physician-entrepreneur with extensive experience in the healthcare industry, having previously worked as a hospitalist and held leadership roles in various medical institutions. His work with Redivus Health has garnered recognition for its impact on reducing healthcare variability and enhancing the quality of patient care.
2024 KLAS Emerging Solutions Recognition: Redivus Health was named to the KLAS Emerging Solutions Top 20 Report for its innovative contributions to healthcare. It was ranked #1 for improving patient outcomes and #2 for enhancing clinician experiences with its resuscitation software.
Expansion and Innovation: In the early part of 2024, Redivus Health continued to innovate its software platforms to better assist healthcare providers in emergency situations, acting as a "virtual coach" to ensure adherence to clinical guidelines, thereby reducing errors and saving lives.
Inspirations and Milestones: Jeff Dunn, inspired by "The Checklist Manifesto" by Atul Gawande, integrated checklist methodologies into the development of Redivus software, which has been essential in improving the reliability and predictability of medical care delivery.
COVID-19 Impact: During the COVID-19 pandemic, Redivus Health made its "Code Blue" app free for healthcare providers, aiding them in managing respiratory and cardiac arrest during the crisis. This initiative helped spread crucial real-time decision support to front-line workers.
Attribute | Information |
---|---|
Full Name | Jeff Dunn |
Born | Not publicly available |
Nationality | American |
Occupation | CEO of Redivus Health |
Known For | Founder of Redivus Health, Innovator in medical technology |
Net Worth | Not publicly available |
Education | D.O. from Kansas City University; MBA from Rockhurst University |
Jeff Dunn grew up with an interest in medicine and technology, which later influenced his career in healthcare innovation. He attended Rockhurst High School before pursuing higher education at Rockhurst University, where he obtained a Bachelor of Science in Biology with a Pre-Med focus. He then attended Kansas City University, earning his Doctor of Osteopathic Medicine (D.O.) degree. After completing his residency in Internal Medicine at the University of Kansas Medical Center, Jeff further expanded his expertise by obtaining an MBA from Rockhurst University, equipping him with business acumen crucial for his entrepreneurial ventures.
Jeff Dunn's professional journey has been marked by a strong commitment to enhancing healthcare delivery. His career began with roles as a hospitalist, eventually becoming the Chairman of Medicine and Physician Quality Leader at Saint Luke's Health System.
Currently, Jeff Dunn is focused on expanding the capabilities and reach of Redivus Health. The company's software is designed to guide medical professionals through evidence-based protocols, acting as a decision-making aid in high-stakes scenarios. This work has significantly impacted healthcare by reducing errors and improving patient outcomes across numerous hospitals and healthcare facilities. Under Jeff's leadership, Redivus Health continues to set new standards in healthcare innovation and quality improvement.
Jeff Dunn exemplifies the interface of medical expertise with entrepreneurial resolve, striving to innovate and improve the healthcare system through technology. His work with Redivus Health not only contributes to immediate improvements in patient care but also sets a benchmark for future healthcare solutions. Jeff Dunn's continued efforts in healthcare technology promise significant advancements, potentially revolutionizing how medical providers respond during critical events, thereby fostering safer, more effective patient care globally.